Systematic review of Mendelian randomization studies on risk of cancer

G Markozannes, A Kanellopoulou, O Dimopoulou… - BMC medicine, 2022 - Springer
Background We aimed to map and describe the current state of Mendelian randomization
(MR) literature on cancer risk and to identify associations supported by robust evidence …

MYBL2 amplification in breast cancer: molecular mechanisms and therapeutic potential

R Bayley, C Ward, P Garcia - Biochimica et Biophysica Acta (BBA)-Reviews …, 2020 - Elsevier
The MYBL2 gene, also known as B-MYB, is essential to regulate vital cellular processes
including cell proliferation, differentiation and DNA repair. Changes in these pathways can …

Cell fate reprogramming in the era of cancer immunotherapy

O Zimmermannova, I Caiado, AG Ferreira… - Frontiers in …, 2021 - frontiersin.org
Advances in understanding how cancer cells interact with the immune system allowed the
development of immunotherapeutic strategies, harnessing patients' immune system to fight …

Genetic insights into carbohydrate sulfotransferase 8 and its impact on the immunotherapy efficacy of cancer

WC Chou, WT Chen, CT Kuo, YM Chang, YS Lu, CW Li… - Cell Reports, 2024 - cell.com
Immune checkpoint blockade (ICB) is a promising therapy for solid tumors, but its
effectiveness depends on biomarkers that are not precise. Here, we utilized genome-wide …

PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 …

V Guarneri, MV Dieci, G Bisagni, AA Brandes… - Clinical Cancer …, 2020 - AACR
Purpose: We explored the prognostic effect of PIK3CA mutation in HER2+ patients enrolled
in the ShortHER trial. Patients and Methods: The ShortHER trial randomized 1,253 patients …

A common variant in 11q23. 3 associated with hyperlipidemia is mediated by the binding and regulation of GATA4

WC Chou, WT Chen, CY Shen - NPJ Genomic Medicine, 2022 - nature.com
Large-scale genome-wide associations comprising multiple studies have identified
hundreds of genetic loci commonly associated with hyperlipidemia-related phenotypes …

UACA locus is associated with breast cancer chemoresistance and survival

Q Zhu, E Schultz, J Long, JM Roh, E Valice… - NPJ breast …, 2022 - nature.com
Few germline genetic variants have been robustly linked with breast cancer outcomes. We
conducted trans-ethnic meta genome-wide association study (GWAS) of overall survival …

Construction of an immunogenomic risk score for prognostication in colon cancer

H Zhang, C Qin, H Gan, X Guo, L Zhang - Frontiers in genetics, 2020 - frontiersin.org
Immune-related genes (IRGs) play regulatory roles in the immune system and are involved
in the initiation and progression of colon cancer. This study aimed to develop an …

XCL1 aggravates diabetic nephropathy-mediated renal glomerular endothelial cell apoptosis and inflammatory response via regulating p53/nuclear factor-kappa B …

Y Zhang, X Chen, Y Fan, J Liu, L Yuan - Nephron, 2022 - karger.com
Background: Glomerular endothelial cell damage plays an important role in the occurrence
and development of diabetic nephropathy (DN). Objectives: This study aimed to clarify the …

The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study

X Yu, Y Zhang, Y Lin, S Zou, P Zhu, M Song, F Fu… - Frontiers in …, 2023 - frontiersin.org
Background: Despite the potential role of several chemokines in the migration of cytotoxic
immune cells to prohibit breast cancer cell proliferation, a comprehensive view of …